Markets › India › NSE › ALIVUS

Alivus Life Sciences Ltd

NSE:ALIVUSHealthcare

₹1,268.60−3.12%At closeAt close · Mon 19 Oct · ≈ AED 49.01 · Market cap $1.69B · Next earnings Thu 5 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2024	FY2025	Current · undated	YoY
Gross margin	34.4%	31.4%	33.5%	54.5%	32.2%	44.6%	—	—
Operating margin	29.8%	27.6%	27.6%	39.3%	26.3%	28.3%	28.3%	+0.0 pts
Net margin	18.9%	20.1%	21.6%	20.6%	20.5%	22.1%	22.1%	+0.0 pts
EBITDA margin	31.8%	30.2%	31.1%	30.1%	30.2%	32.6%	—	—
Return on equity	46.7%	20.4%	21.8%	20.2%	17.2%	16.9%	16.9%	+0.0 pts
Return on assets	17.6%	16.9%	17.3%	16.5%	14.2%	14.2%	14.2%	+0.0 pts
Return on capital employed	71.5%	27.7%	27.1%	37.2%	21.2%	20.8%	—	—
Debt / equity	1.2×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	46.7%	0.1%	0.7%	0.6%	1.7%	1.4%	—	—
Interest coverage	6.3×	20.6×	1,092.1×	580.8×	258.4×	134.4×	—	—
Current ratio	1.1×	4.6×	3.7×	4.4×	5.0×	5.2×	5.2×	+0.0%
Quick ratio	0.7×	3.3×	2.5×	2.8×	3.5×	3.9×	—	—
Cash ratio	0.1×	1.3×	0.6×	0.7×	0.2×	0.0×	0.0×	+0.0%
Asset turnover	0.9×	0.8×	0.8×	0.8×	0.7×	0.6×	—	—
Inventory turnover	2.4×	2.8×	2.4×	1.6×	2.4×	2.0×	—	—
Receivables turnover	3.0×	3.1×	2.7×	3.0×	2.3×	2.4×	—	—
Dividend payout	0.0%	30.7%	82.6%	58.5%	0.0%	10.9%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.